Fengxia Lin

494 total citations
21 papers, 380 citations indexed

About

Fengxia Lin is a scholar working on Molecular Biology, Pharmacology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Fengxia Lin has authored 21 papers receiving a total of 380 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 6 papers in Pharmacology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Fengxia Lin's work include Ferroptosis and cancer prognosis (3 papers), Cancer-related molecular mechanisms research (3 papers) and Berberine and alkaloids research (2 papers). Fengxia Lin is often cited by papers focused on Ferroptosis and cancer prognosis (3 papers), Cancer-related molecular mechanisms research (3 papers) and Berberine and alkaloids research (2 papers). Fengxia Lin collaborates with scholars based in China and South Korea. Fengxia Lin's co-authors include Yinzhi Song, Zijun Wu, Ke Xiao, Xiaojing Huang, Yiying Yang, Zhiwen Li, Liang Li, Xiao Ke, Xun Hu and Bin Deng and has published in prestigious journals such as International Journal of Nanomedicine, Biomedicine & Pharmacotherapy and Journal of Pharmacy and Pharmacology.

In The Last Decade

Fengxia Lin

21 papers receiving 374 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fengxia Lin China 10 216 106 39 36 36 21 380
Yinzhi Song China 9 191 0.9× 96 0.9× 34 0.9× 32 0.9× 37 1.0× 16 330
Man Luo China 13 322 1.5× 156 1.5× 45 1.2× 22 0.6× 65 1.8× 20 541
Xiaorong Shui China 12 234 1.1× 97 0.9× 18 0.5× 39 1.1× 35 1.0× 31 492
Eskandar Qaed China 12 236 1.1× 78 0.7× 25 0.6× 23 0.6× 20 0.6× 30 442
Liquan Tong China 14 173 0.8× 53 0.5× 59 1.5× 20 0.6× 17 0.5× 17 513
Qiaoyan Guo China 12 195 0.9× 36 0.3× 27 0.7× 30 0.8× 21 0.6× 33 495
Zhigang Luo China 12 224 1.0× 95 0.9× 14 0.4× 22 0.6× 14 0.4× 23 427
Ying Huai China 11 314 1.5× 81 0.8× 67 1.7× 50 1.4× 19 0.5× 24 538
Junmei Ye China 14 223 1.0× 47 0.4× 25 0.6× 32 0.9× 81 2.3× 27 431

Countries citing papers authored by Fengxia Lin

Since Specialization
Citations

This map shows the geographic impact of Fengxia Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fengxia Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fengxia Lin more than expected).

Fields of papers citing papers by Fengxia Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fengxia Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fengxia Lin. The network helps show where Fengxia Lin may publish in the future.

Co-authorship network of co-authors of Fengxia Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Fengxia Lin. A scholar is included among the top collaborators of Fengxia Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fengxia Lin. Fengxia Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Tu, Jinchun, et al.. (2024). Anticipation and Verification of Dendrobium-Derived Nanovesicles for Skin Wound Healing Targets, Predicated Upon Immune Infiltration and Senescence. International Journal of Nanomedicine. Volume 19. 1629–1644. 17 indexed citations
3.
Lin, Fengxia, et al.. (2024). Xihuang pills targeting the Warburg effect through inhibition of the Wnt/β-catenin pathway in prostate cancer. Heliyon. 10(12). e32914–e32914. 1 indexed citations
4.
Lin, Fengxia, et al.. (2024). The Relationship between Alzheimer's Disease and Ferroptosis: A Bibliometric Study Based on Citespace. Current Alzheimer Research. 21(8). 566–577. 1 indexed citations
5.
Jiang, Feng, Xu Zhou, Weiwei Zhang, et al.. (2022). Transcriptomic Analysis Uncovers Immunogenic Characteristics of Ferroptosis for Myocardial Infarction and Potential Therapeutic Prediction of Chinese Herbs. Evidence-based Complementary and Alternative Medicine. 2022. 1–12. 5 indexed citations
6.
Lu, Yao, et al.. (2022). Corrigendum: Effects of Rhodiola Rosea Supplementation on Exercise and Sport: A Systematic Review. Frontiers in Nutrition. 9. 928909–928909. 2 indexed citations
7.
Jiang, Feng, et al.. (2022). Effects of a natural nutritional supplement on immune cell infiltration and immune gene expression in exercise-induced injury. Frontiers in Nutrition. 9. 987545–987545. 5 indexed citations
8.
Lu, Yao, et al.. (2022). Effects of Rhodiola Rosea Supplementation on Exercise and Sport: A Systematic Review. Frontiers in Nutrition. 9. 856287–856287. 20 indexed citations
10.
11.
Huang, Yiteng, et al.. (2020). <p>Berberine Attenuates Arterial Plaque Formation in Atherosclerotic Rats with Damp-Heat Syndrome via Regulating Autophagy</p>. Drug Design Development and Therapy. Volume 14. 2449–2460. 20 indexed citations
12.
Lin, Fengxia, et al.. (2020). <p>Hydrogen Sulfide Protects Against High Glucose-Induced Human Umbilical Vein Endothelial Cell Injury Through Activating PI3K/Akt/eNOS Pathway</p>. Drug Design Development and Therapy. Volume 14. 621–633. 91 indexed citations
13.
Lin, Fengxia, et al.. (2020). Semen Brassicae reduces thoracic aortic remodeling, inflammation, and oxidative damage in spontaneously hypertensive rats. Biomedicine & Pharmacotherapy. 129. 110400–110400. 12 indexed citations
14.
Lin, Fengxia, et al.. (2020). β‐Sitosterol Protects against Myocardial Ischemia/Reperfusion Injury via Targeting PPARγ/NF‐κB Signalling. Evidence-based Complementary and Alternative Medicine. 2020(1). 2679409–2679409. 31 indexed citations
15.
Lin, Fengxia, Yinzhi Song, Liang Li, et al.. (2019). YBX-1 mediated sorting of miR-133 into hypoxia/reoxygenation-induced EPC-derived exosomes to increase fibroblast angiogenesis and MEndoT. Stem Cell Research & Therapy. 10(1). 263–263. 92 indexed citations
16.
Pan, Yan, Wei Wu, L. Li, et al.. (2019). Myocardial hypertrophy is improved with berberine treatment via long non-coding RNA MIAT-mediated autophagy. Journal of Pharmacy and Pharmacology. 71(12). 1822–1831. 26 indexed citations
17.
Li, Shi, Dan Mao, Weijun Peng, et al.. (2018). Use of Jianpi Jiedu Herbs in Patients with Advanced Colorectal Cancer: A Systematic Review and Meta‐Analysis. Evidence-based Complementary and Alternative Medicine. 2018(1). 6180810–6180810. 22 indexed citations
18.
Chen, Yaqin, et al.. (2018). Internal mammary artery injury during percutaneous coronary intervention: a case report. BMC Cardiovascular Disorders. 18(1). 222–222. 1 indexed citations
19.
Xiao, Li, Fengxia Lin, Rong Xiao, et al.. (2016). Multiple myeloma-associated skin light chain amyloidosis: A case of misdiagnosis. Oncology Letters. 11(6). 3617–3620. 2 indexed citations
20.
Lin, Fengxia, et al.. (2016). Chinese medicine for outcomes in colorectal cancer patients: A retrospective clinical study. Chinese Journal of Integrative Medicine. 23(9). 648–653. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026